Governments and public institutions must tackle a complex equation, aiming to ensure equitable and early access to the best care while controlling costs for society. In the face of an aging population, the rise of chronic diseases, a dwindling medical workforce, and significant access issues to primary care, several reforms have attempted to drive the transformation of our healthcare system.
To achieve this, it is essential to identify convergences between public and private stakeholders, develop interprofessional collaborations, observe best practices implemented abroad, and commit, over the long term, to integrating and financing new technologies.
Our Support
We support pharmaceutical industry players in tackling these challenges with our expertise in:
Market Access
Defining and implementing patient access strategies, preparing early access and evaluation dossiers, supporting pricing negotiations for healthcare products, and developing Stakeholder Engagement Plans, etc.
Public Affairs
Structuring strategic roadmaps and advocacy, forming coalitions, deploying awareness campaigns involving public and private stakeholders, lobbying, organizing events bringing together public decision-makers and stakeholders, establishing observatories, etc.
Strategy and Transformation
Defining strategic roadmaps, supporting organizational transformation, analyzing and assisting in the strengthening of patient pathways, supporting the development of solutions and services that create value for patients, assisting in digital transformation, engaging in CSR initiatives, seeking funding, etc.
Training, Information, and Publications
Analyzing current issues, publishing reports, conducting deep-dives for teams, training your partners (patients, healthcare professionals, leadership coaching and board committees on key healthcare system issues), strategic monitoring, preparing informational reports, etc.
Related posts
Would you like to speak with our experts?
